The Relationship Between Insulin PSTI Polymorphism and Prostate Cancer in Turkish Population
Abstract
Purpose: There is positive correlation between insulin and various cancers such as colon, lung and endometrium. Protate cancer is the one of them. The aim of this study, to determine the incidance of INS+1127 PstI polymorphism, located in the 3" UTR of insulin gene, between prostate cancer cases and controls and to clarify if this polymorphism have any role in the etiology of prostate cancer. Methods: We investigated 71 prostate cancer cases and 119 normal controls unrelated to patients. INS+1127 PstI polymorphism was investigated with PCR and RFLP method. Results: At the end of study; INS+1127 PstI polymorphism genotypes out to be 67.6 % CC, 28.2 % CT, 4.2 % TT among prostatic cancer individuals and 78.2% CC, 21% CT, 0.8% TT among control group individuals. Conclusion: As a result, there was no significant difference between patients and control group, in the genotype distribution.
Keywords
Kaynakça
- Barbisan F, Mazzucchelli R, Scarpelli M, Lopez-Beltran A, Cheng L, Kirkali Z et al. Urothelial and incidental prostate carcinoma in prostates from cystoprostatectomies for bladder cancer: is there a relationship between urothelial and prostate cancer? BJU Int. 2009; 103: 1058-63.
- Bergman M, Ahnström M, Palmebäck Wegman P, Wingren S. Polymorphism in the manganese superoxide dismutase (MnSOD) gene and risk of breast cancer in young women. J Cancer Res Clin Oncol. 2005; 131: 439
- Claeys GB, Sarma AV, Dunn RL, Zuhlke KA, BeebeDimmer J, Montie JE et al. INSPstI polymorphism and prostate cancer in African-American men. Prostate. 2005; 65: 83-7.
- Ho GYF, Melman A, Liu SM, Li M, Yu H, Negassa A et al. Polymorphism of the insulin gene is associated with increased protate cancer risk. Br J Cancer. 2003; 88: 263Hsing AW, Chua S Jr, Gao YT, Gentzschein E, Chang L, Deng J et al. Prostate cancer risk and serum levels of insulin and leptin: a population-based study. J Natl Cancer Inst. 2001; 93: 783-9.
- Stattin P, Kaaks R. Re: Insulin resistance and prostate cancer risk. J Natl Cancer Inst. 2003; 95: 1086-7.
- Del Guidice ME, Fantus IG, Ezzat S, McKeown-Eyssen G, Page D, Goodwin PJ. Insulin and related factors in premenopausal breast cancer risk. Breast Cancer Res Treat. 1998; 47: 111-20.
- Gamayunova VB, Bobrov YuF, Tsyrlina EV, Evtushenko TP, Berstein LM. Comperative study of blood insulin levels in breast and endometrial cancer patients. Neoplasma. 1997; 44: 123-6.
- Goodwin PJ, Ennis M, Pritchard KI, Trudeau ME, Koo J, Madarnas Y et al. Fasting insulin and outcome in earlystage breast cancer: results of a prospective cohort study. J Clin Oncol. 2002; 20: 42-51.
- Josefson D. High insulin levels linked to deaths from breast cancer. BMJ. 2000; 320: 1496.
- Ruijter E, van dee Kaa C, Miller G, Ruiter D, Debruyne F, Schalken J. Molecular genetics and epidemiology of prostate carcinoma. Endocr Rev. 1999; 20: 22-45.
